European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission We conducted a retrospective cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback